Blog Post Highlights Journal Article On Developing TB Treatments For Underserved Populations

Center for Global Health Policy’s “Science Speaks”: Children, people with HIV, pregnant women, and others underserved by TB drug development present ethical imperative, opportunities for global disease approaches, authors say
Antigone Barton, senior editor and writer of “Science Speaks,” discusses “an article [published] in a recently released Journal of Infectious Diseases supplement on tuberculosis drug development [that] explores the challenges [of] developing products of appropriate doses and formulations for children, people with HIV, people with diabetes, and pregnant women, as well as the opportunities that meeting those challenges present…” (6/1).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.